CDKN2B and melanoma: Fifty nontargeting sgRNAs were incorporated as negative controls as well as positive controls against five known melanoma-associated lncRNAs (BANCR, CDKN2B-AS1, HOTAIR, MALAT1, and SAMMSON; Supplementary Table S2).